Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SUPN · as of Jun 9, 2026
Key Statistics
Explore Supernus Pharmaceuticals, Inc. Data
supn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 64.3%
The SUPN analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $60.00, representing +34.89% upside from the current price of $44.48.
Competitors & Peers
supn competitorsSUPN
AMRX
BHC
CGON
CNTA
GRALStock Performance
Full HistoryAbout Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States. Its portfolio of markete…
what is supernus pharmaceuticals, inc. · supn stock overview · supernus pharmaceuticals, inc. company profile · who is supernus pharmaceuticals, inc. ceo · supn NASDAQ · supernus pharmaceuticals, inc. headquarters · supernus pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Supernus Pharmaceuticals, Inc. (SUPN) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 1, 2012. As of the latest trading session, SUPN stock price is $44.48, with a market capitalization of $2.6B. The stock has returned +33.69% over the past 12 months and -10.50% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Supernus Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $60.00. In fiscal year 2025, Supernus Pharmaceuticals, Inc. reported revenue of $719.0M and net income of -$38.5M. For detailed data — including Supernus Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Supernus Pharmaceuticals, Inc. (SUPN) stock price is $44.48. The stock is traded on NASDAQ under the ticker symbol SUPN. The 52-week range is $30.83 – $59.68.